Chengjie Lin

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Locally Advanced

Signaling Pathway

Epithelial Mesenchymal Transition

Top Venues

Cell death & disease

Cell & bioscience

This page only lists publications with an associated author ORCID identifier.

Publications

Chengjie Lin, Ting Li, Yan Wang, Shihui Lai, Yue Huang, Zhenyun Guo, Xiang Zhang, ShanGeng Weng
METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation. Cell death & disease 14 (3) (2023)
Chengjie Lin, Ting Li, Yan Wang, Shihui Lai, Yue Huang, Zhenyun Guo, Xiang Zhang, ShanGeng Weng
Correction: METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation. Cell death & disease 14 (7) (2023)
Chengjie Lin, Ting Li, Yan Wang, Shihui Lai, Yue Huang, Zhenyun Guo, Xiang Zhang, ShanGeng Weng
METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation. Cell death & disease 14 (3) (2023)
Chengjie Lin, Ting Li, Yan Wang, Shihui Lai, Yue Huang, Zhenyun Guo, Xiang Zhang, ShanGeng Weng
METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation. Cell death & disease 14 (3) (2023)
Shihui Lai, Yan Wang, Ting Li, Yihong Dong, Yihao Lin, Liang Wang, Shangeng Weng, Xiang Zhang, Chengjie Lin
N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer. Cell & bioscience 12 (1) (2022)